menu
    • menu

    Company profile for Jade Biosciences

    NEW Drugs in Dev: 2
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Jade Biosciences, headquartered in Waltham, MA, is dedicated to developing a pipeline of potentially best-in-class therapies aimed at redefining the standard of care for patients with autoimmune conditions. By focusing on innovative treatments, Jade strives to significantly improve patient outcomes and advance the management of autoimmune diseases.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Jade BiosciencesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1625 North Market Blvd., Suite N112, Sacramento
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://jadebiosciences.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/jade-biosciences/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Jade Biosciences Announces Inducement Grant Under Nasdaq Rule
    Jade Biosciences Announces Inducement Grant Under Nasdaq Rule

    23 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/23/3279724/0/en/jade-biosciences-announces-inducement-grant-under-nasdaq-listing-rule-5635-c-4.html

    GLOBENEWSWIRE
    23 Apr 2026
    Share Share
    Jade Biosciences Reveals 2025 Financials And Corporate Update
    Jade Biosciences Reveals 2025 Financials And Corporate Update

    06 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/06/3250954/0/en/Jade-Biosciences-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results-and-Provides-Corporate-Update.html

    GLOBENEWSWIRE
    06 Mar 2026
    Share Share
    Jade Biosciences To Participate In Upcoming Conferences
    Jade Biosciences To Participate In Upcoming Conferences

    11 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/11/3236116/0/en/Jade-Biosciences-to-Participate-in-Upcoming-Conferences.html

    GLOBENEWSWIRE
    11 Feb 2026
    Share Share
    Jade Bio Outlines Key Objectives & Strategy to Advance Pipeline
    Jade Bio Outlines Key Objectives & Strategy to Advance Pipeline

    05 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/05/3212593/0/en/Jade-Biosciences-Outlines-Key-2026-Objectives-and-Strategy-to-Advance-Pipeline-of-Potentially-Best-in-Class-Monoclonal-Antibodies-Across-Multiple-Autoimmune-Diseases-Ahead-of-the-4.html

    GLOBENEWSWIRE
    05 Jan 2026
    Share Share
    Jade Biosciences Announces $45 Million Private Placement
    Jade Biosciences Announces $45 Million Private Placement

    15 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/15/3205275/0/en/Jade-Biosciences-Announces-45-Million-Private-Placement.html

    GLOBENEWSWIRE
    15 Dec 2025
    Share Share
    Jade Biosciences Reveals Q3 2025 Financials And Corporate Update
    Jade Biosciences Reveals Q3 2025 Financials And Corporate Update

    13 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/13/3187849/0/en/Jade-Biosciences-Reports-Third-Quarter-2025-Financial-Results-and-Provides-Corporate-Update.html

    GLOBENEWSWIRE
    13 Nov 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search